Document is current
Any future updates will be listed below
-
Authors
Rimpeläinen, Kaarina
Jansson Sigfrids, Fanny
Gordin, Daniel
Klemetti, Miira M.
Harjutsalo, Valma
Groop, Per-Henrik
Thorn, Lena M.
,
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 26 May 2025
First Online: 14 June 2025
Declarations
:
: F.J.S. has received lecture fees from AstraZeneca and Boehringer Ingelheim. P.-H.G. has received investigator-initiated research grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, Merck Sharp & Dohme, Mundipharma, Nestle, Novartis, Novo Nordisk and Sanofi; and has received lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Merck Sharp & Dohme, Medscape, Novartis, Novo Nordisk, PeerVoice, and Sanofi. D.G. Lecture or Advisory Board Honoraria: Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, GE Healthcare, Harald AI, Novo Nordisk, Ratiopharm.
